Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
131.20    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.60 (0.46%)
Market Cap: £270.21m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Grant under Performance Share Plan

3 Apr 2023 14:03

RNS Number : 1905V
Forterra plc
03 April 2023
 

3 April 2023

Forterra plc

Grant under Performance Share Plan

Forterra plc (the "Company") announces that on 3 April 2023 awards over ordinary shares of £0.01 each in the capital of the Company were granted to certain Directors and persons discharging managerial responsibility ("PDMRs") under the Forterra plc Performance Share Plan ("PSP") as follows:

Name of Director / PDMR

Number of Shares over which the PSP Award is granted

Neil Ash

(Chief Executive Officer Designate) 

490,673*

Ben Guyatt

(Chief Financial Officer)

216,989

George Stewart

(Strategic Projects Director)

68,098

Adam Smith

(Commercial Director)

68,098

Shahbaz Idriss

(HR Director)

60,210

Darren Rix

(Managing Director - Bison Precast)

55,445

Matt Day

(IT Director)

55,429

Steve Jeynes

(Production Director)

55,261

Ashley Thompson

(Company Secretary)

14,727

Other management

 

331,465

Total awards granted

 

1,416,395

No consideration was paid for the grant of the awards which are structured as nominal cost options at an option exercise price of £0.01 per Ordinary Share. The number of Ordinary Shares granted under the award has been calculated using a share price of £1.97 being an average mid-market quotation as derived from the London Stock Exchange Daily Official List for the last 5 days of trading.

The vesting of an award is subject to the satisfaction of performance conditions which have been set by the Remuneration Committee of the Board of Directors of the Company. The awards are subject to TSR, EPS, and ESG performance measures. The awards will normally vest on 3 April 2026, subject to the achievement of the performance conditions and the participant being a director or employee within the Company's group at that time.

\* This award includes additional options over 126,904 Ordinary Shares in place of the cash value of his 2022 bonus as agreed by the Company.

Further information regarding the PSP is set out in the Annual Report and Accounts.

Grant for amounts foregone

In addition, under the 2020 Remuneration Policy for amounts foregone from a previous employer Neil Ash on joining the Company has been awarded 207,784 Ordinary Shares. No consideration was paid for the grant of this award which are structured as nominal cost options at an option exercise price of £0.01 per Ordinary Share. These Ordinary Shares will count towards the requirement to build up and maintain a 200% of salary shareholding in Forterra.

The above notification is intended to satisfy the Company's obligations under Article 19 of the Market Abuse Regulations and Listing Rule 9.4.2R.

Enquiries

Forterra plc:

+44 (0) 1604 707 600

Ashley Thompson (Company Secretary)

FTI Consulting (public relations adviser to Forterra):

+44 (0) 20 3727 1340

Richard Mountain

Nick Hasell

Further information relating to the Company and its group can be found at: www.forterra.co.uk/investors

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKZGGDZFRGFZM
Date   Source Headline
24th Nov 20208:24 amRNSProgressive publishes new research
24th Nov 20207:00 amRNSTrading Statement
5th Nov 20205:09 pmRNSHolding(s) in Company
9th Oct 20203:45 pmRNSGrant of Options under 2020 SAYE Scheme
18th Sep 202010:12 amRNSGrant under Performance Share Plan
18th Sep 20209:40 amRNSHolding(s) in Company
14th Sep 20201:50 pmRNSProgressive publishes new research
14th Sep 20209:05 amRNSHolding(s) in Company
10th Sep 20207:00 amRNS2020 HALF YEAR RESULTS
7th Sep 20205:34 pmRNSHolding(s) in Company
14th Aug 20201:45 pmRNSHolding(s) in Company
30th Jul 20204:54 pmRNSHolding(s) in Company
16th Jul 202010:09 amRNSHolding(s) in Company
8th Jul 20203:02 pmRNSHolding(s) in Company
8th Jul 202010:32 amRNSHolding(s) in Company
7th Jul 20203:27 pmRNSHolding(s) in Company
7th Jul 20203:25 pmRNSHolding(s) in Company
7th Jul 20202:20 pmRNSTotal Voting Rights and Capital
7th Jul 202012:44 pmRNSDirector/PDMR Shareholding
7th Jul 20207:00 amRNSHolding(s) in Company
6th Jul 20203:34 pmRNSDirector Shareholdings
6th Jul 20203:32 pmRNSPCA Shareholdings
2nd Jul 20207:00 amRNSResults of Placing
1st Jul 20204:41 pmRNSProposed placing of new ordinary shares
1st Jul 20204:40 pmRNSFinancing update and proposed equity placing
25th Jun 202010:44 amRNSHolding(s) in Company
24th Jun 20208:02 amRNSHolding(s) in Company
22nd Jun 20203:27 pmRNSHolding(s) in Company
16th Jun 20207:55 amRNSHolding(s) in Company
10th Jun 202012:53 pmRNSHolding(s) in Company
10th Jun 202012:45 pmRNSHolding(s) in Company
3rd Jun 20207:00 amRNSTrading Update
26th May 20202:25 pmRNSDirector/PDMR Shareholding
14th May 20201:45 pmRNSResult of AGM
14th May 202012:08 pmRNSSecond Price Monitoring Extn
14th May 202012:02 pmRNSPrice Monitoring Extension
28th Apr 20207:00 amRNSRecommencement of operations
16th Apr 202012:07 pmRNSSecond Price Monitoring Extn
16th Apr 202012:02 pmRNSPrice Monitoring Extension
15th Apr 20207:00 amRNSAnnual Report 2019 and AGM 2020
26th Mar 20209:07 amRNSHolding(s) in Company
24th Mar 20202:50 pmRNSUpdate on Covid-19
24th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20205:41 pmRNSDirector/PDMR Shareholding
13th Mar 20209:55 amRNSHolding(s) in Company
13th Mar 20209:51 amRNSDirector/PDMR Shareholding
10th Mar 20207:00 amRNS2019 FULL YEAR RESULTS
3rd Mar 20207:00 amRNSEmployee Benefit Trust Share Purchase
24th Feb 20209:23 amRNSHolding(s) in Company
6th Feb 202010:59 amRNSEmployee Benefit Trust Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.